Infectious Diseases
Feature
Man with COVID finally tests negative after 411 days
The man was treated with a mixture of neutralizing monoclonal antibodies.
Latest News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.
News from the FDA/CDC
Mid-October flulike illness cases higher than past 5 years
The 2022-2023 season is already “gathering speed … about a month early,” one expert said.
From the Journals
‘Unappreciated’ ties between COVID and gut dysbiosis
“Now that we have uncovered the source of this bacterial imbalance, physicians can better identify those coronavirus patients most at risk of a...
From the Journals
Oral FMT on par with colonic FMT for recurrent C. difficile
“We present one of the largest cohorts involving people who received capsule FMT.”
From the Journals
Recurrent urinary tract infections: What’s good prophylaxis?
Study results on long-term prevention using cranberry products are inconsistent, and they are not recommended in the updated guideline.
From the Journals
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults...
Conference Coverage
RBX2660 shows promise in breaking the cycle of recurrent C. difficile
“Even when you expand the patient population to make it more generalizable, we’re still seeing both a high cure rate and a high success rate.”
From the Journals
Droplet dispersal in sterile processing units far exceeds guideline limit
“The guidelines say that droplets stop at 3 or 4 feet, and they don’t.”
Feature
Is it flu, RSV, or COVID? Experts fear the ‘tripledemic’
Predicting exactly when cases will peak is difficult.